Novartis
Principal Investigator: Dr Mary Mooney
Primary Funding Source: Novartis Ireland Ireland
Grant Value: €12,000
The primary objective of the study is to test the effectiveness of a study-specific blood pressure (B/P) monitor, and a study-specific weighing scales, together with the already available fluid heart tracker app (triple pack) in patients with heart failure. The secondary objective is to qualitatively assess participants and healthcare providers perceived usefulness and clinical acceptability of the triple pack.